About Careers Internship MedBlog Contact us

New Device Helps to Find Out Skin Cancer Triggering Moles

by VR Sreeraman on August 7, 2008 at 12:27 PM
 New Device Helps to Find Out Skin Cancer Triggering Moles

Scared if that mole on your face could one day turn out to be skin cancer? Well, then Molemate is sure to allay your fears.

Molemate is a non-invasive, rapid and painless mole-screening device that can enable a medical practitioner to quickly scan one's moles.


It may make it possible to detect the early stages of skin cancer by allowing doctors to screen and evaluate a mole within seconds.

Based on their observations, the doctors may either reassure patients that their moles are harmless or refer them on to a specialist.

According to its manufacturers, the hand-held MoleMate device instantly analyses changes in the main components of skin, thus providing an early diagnosis.

Currently, Medicalternative, the Edinburgh private clinic, is the only one to provide such scans, charging 100 pounds for screening and evaluation.

"MoleMate is a non-invasive, rapid and painless mole screening device that enables a medical practitioner to quickly scan your moles, showing information up to 2mm under the skin. This can assist them in making an instant decision on the health of the mole," the Scotsman quoted a spokeswoman at Medicalternative as saying.

This device uses light wave technology to break in two millimetres beneath the surface of the skin.

The researchers can then use the differences in the light waves that return to detect potentially harmful changes in colour, blood flow, the skin pigment melanin and collagen that may signal progression to cancer unless treated.

Dr Lindsey Myskow, a part-time NHS GP who runs the screening clinics, said: "We scan the mole for a number of features to see whether it is suspicious or not. The scanner measures these pretty accurately and helps with diagnosis.

The device has been manufactured by Cambridge-based Astron Clinica, which was founded by scientist Symon Cotton in 1998.

Source: ANI
Font : A-A+



Recommended Readings

Latest Cancer News

Innovative Cancer Implant Technology Holds Promise to Cut Death Rates by Half
HAMMR's small size permits minimally invasive implantation, monitoring cancer status, and dynamically adjusting immunotherapy, akin to a glucose monitor.
Personalized Vaccine and T Cell Therapy for Ovarian Cancer Patients
The combination of the personalized cancer vaccine with ACT led to ovarian cancer control in few patients within a span of three months, stated study results.
Kinase-Targeted Therapy Revolutionizes Colorectal Cancer Care
Uncovering key kinases in tumor growth and invasion is crucial for improving targeted therapies in advanced-stage colorectal cancer.
Novel Photo-Oxidation Therapy Holds Promise for Anticancer Treatment
The study findings validate metal-enhanced photo-oxidation for future metal-based anticancer drugs.
Mutations in 11 Genes Linked to Aggressive Prostate Cancer
Mutations in 11 genes are linked to aggressive forms of prostate cancer, which may present novel therapeutic and therapy options.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
Greetings! How can I assist you?MediBot

New Device Helps to Find Out Skin Cancer Triggering Moles Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests